XML 122 R105.htm IDEA: XBRL DOCUMENT v3.22.1
Revision - Statement of Operations (Details) - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Sep. 30, 2021
Jun. 30, 2021
Mar. 31, 2021
Dec. 31, 2021
Dec. 31, 2020
Dec. 31, 2019
Revenue:            
Capitated revenue       $ 1,529,120 $ 796,373 $ 340,901
Fee-for-service and other revenue       80,249 35,203 20,483
Total revenue       1,609,369 831,576 361,384
Operating expenses:            
Third-party medical costs       1,231,047 564,987 242,572
Direct patient expense       179,353 101,358 42,100
Selling, general and administrative expenses       252,133 103,962 59,148
Depreciation and amortization expense       49,441 18,499 6,822
Transaction costs and other       44,262 42,945 17,583
Change in fair value of contingent consideration       (11,680) 65 2,845
Total operating expenses       1,744,556 831,816 371,070
Loss from operations       (135,187) (240) (9,686)
Other income and expense:            
Interest expense       (51,291) (34,002) (10,163)
Interest income       4 320 319
Loss on extinguishment of debt       (13,115) (23,277) 0
Change in fair value of embedded derivative       0 (12,764) 0
Change in fair value of warrant liabilities       82,914 0 0
Other expenses       (48) (450) (250)
Total other income (expense)       18,464 (70,173) (10,094)
Net income (loss) before income tax expense (benefit)       (116,723) (70,413) (19,780)
Income tax expense (benefit)       14 651 0
Net income (loss)     $ (16,320) $ (116,737) (71,064) (19,780)
As Previously Reported            
Revenue:            
Capitated revenue $ 501,780 $ 379,210 267,051   794,164 343,903
Fee-for-service and other revenue 25,018 13,953 13,084   35,203 20,483
Total revenue 526,798 393,163 280,135   829,367 364,386
Operating expenses:            
Third-party medical costs 379,316 291,816 195,046   564,987 241,089
Direct patient expense 57,708 43,782 34,287   102,284 43,020
Selling, general and administrative expenses 75,926 46,574 34,848   103,962 59,148
Depreciation and amortization expense 16,955 7,945 5,846   18,499 6,822
Transaction costs and other 6,528 16,374 9,239   43,520 17,583
Change in fair value of contingent consideration         65 2,845
Total operating expenses 536,433 406,491 279,266   833,317 370,507
Loss from operations (9,635) (13,328) 869   (3,950) (6,121)
Other income and expense:            
Interest expense (16,023) (9,714) (10,626)   (34,002) (10,163)
Interest income 1 1 1   320 319
Loss on extinguishment of debt 0 (13,225) 0   (23,277) 0
Change in fair value of embedded derivative         (12,764) 0
Change in fair value of warrant liabilities (14,650) 39,215 0   0 0
Other expenses (29) (25) 0   (450) (250)
Total other income (expense) (30,701) 16,252 (10,625)   (70,173) (10,094)
Net income (loss) before income tax expense (benefit) (40,336) 2,924 (9,756)   (74,123) (16,215)
Income tax expense (benefit) 547 (2,023) 714   651 0
Net income (loss) $ (40,883) $ 4,947 $ (10,470)   (74,774) (16,215)
Adjustments            
Revenue:            
Capitated revenue         2,209 (3,002)
Fee-for-service and other revenue         0  
Total revenue         2,209 (3,002)
Operating expenses:            
Third-party medical costs         0 1,483
Direct patient expense         (926) (920)
Selling, general and administrative expenses         0  
Depreciation and amortization expense         0  
Transaction costs and other         (575)  
Change in fair value of contingent consideration         0  
Total operating expenses         (1,501) 563
Loss from operations         3,710 (3,565)
Other income and expense:            
Interest expense         0 0
Interest income         0 0
Loss on extinguishment of debt         0 0
Change in fair value of embedded derivative         0 0
Change in fair value of warrant liabilities         0 0
Other expenses         0 0
Total other income (expense)         0 0
Net income (loss) before income tax expense (benefit)         3,710 (3,565)
Income tax expense (benefit)         0 0
Net income (loss)         $ 3,710 $ (3,565)